These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prediction of bone mass in renal hyperparathyroidism by newly developed bone metabolic markers: evaluation of serum levels of carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen and carboxy-terminal propeptide of type I procollagen. Katagiri M, Fukunaga M, Ohtawa T, Harada T. World J Surg; 1996 Sep; 20(7):753-6; discussion 756-7. PubMed ID: 8678946 [Abstract] [Full Text] [Related]
3. Bone turnover in hyperthyroidism before and after thyrostatic management. Isaia GC, Roggia C, Gola D, Stefano MD, Gallone G, Aimo G, Ardissone P, Mussetta M. J Endocrinol Invest; 2000 Dec; 23(11):727-31. PubMed ID: 11194705 [Abstract] [Full Text] [Related]
4. Antithyroid therapy improves bony manifestations and bone metabolic markers in patients with Graves' thyrotoxicosis. Nagasaka S, Sugimoto H, Nakamura T, Kusaka I, Fujisawa G, Sakuma N, Tsuboi Y, Fukuda S, Honda K, Okada K, Ishikawa S, Saito T. Clin Endocrinol (Oxf); 1997 Aug; 47(2):215-21. PubMed ID: 9302397 [Abstract] [Full Text] [Related]
5. Bone remodelling markers and serum cytokines in patients with hyperthyroidism. Akalin A, Colak O, Alatas O, Efe B. Clin Endocrinol (Oxf); 2002 Jul; 57(1):125-9. PubMed ID: 12100080 [Abstract] [Full Text] [Related]
8. Serum markers of bone metabolism in multiple myeloma: prognostic value of the carboxy-terminal telopeptide of type I collagen (ICTP). Nordic Myeloma Study Group (NMSG). Abildgaard N, Bentzen SM, Nielsen JL, Heickendorff L. Br J Haematol; 1997 Jan; 96(1):103-10. PubMed ID: 9012695 [Abstract] [Full Text] [Related]
12. Characteristics of biochemical markers in patients with metabolic bone disorders. Hoshino H, Kushida K, Takahashi M, Kawana K, Denda M, Yamazaki K, Inoue T. Endocr Res; 1998 Feb; 24(1):55-64. PubMed ID: 9553754 [Abstract] [Full Text] [Related]
13. Abnormal bone turnover in monoclonal gammopathy of undetermined significance: analyses of type I collagen telopeptide, osteocalcin, bone-specific alkaline phosphatase and propeptides of type I and type III procollagens. Vejlgaard T, Abildgaard N, Jans H, Nielsen JL, Heickendorff L. Eur J Haematol; 1997 Feb; 58(2):104-8. PubMed ID: 9111591 [Abstract] [Full Text] [Related]
17. Diagnostic value of serum peptides of collagen synthesis and degradation in dialysis renal osteodystrophy. Mazzaferro S, Pasquali M, Ballanti P, Bonucci E, Costantini S, Chicca S, De Meo S, Perruzza I, Sardella D, Taggi F. Nephrol Dial Transplant; 1995 Feb; 10(1):52-8. PubMed ID: 7724029 [Abstract] [Full Text] [Related]
18. Serum chromogranin A concentration in hyperthyroidism before and after medical treatment. Al-Shoumer KA, Vasanthy BA. J Clin Endocrinol Metab; 2009 Jul; 94(7):2321-4. PubMed ID: 19366853 [Abstract] [Full Text] [Related]